Blog
RSS FeedPosted by Michael Wonder on 06 Jan 2020
Generic makers will appeal ruling that allows California to proceed with law banning pay-to-delay deals
3 January 2020 - A federal judge dealt the pharmaceutical industry a setback by declining to block a new California ...
Posted by Michael Wonder on 05 Jan 2020
'The public deserves to know why' - National intensifies calls for inquiry into PHARMAC after fifth death linked to epilepsy drug Logem
2 January 2020 - The National Party has intensified its call for a ministerial inquiry into PHARMAC's decision to switch ...
Posted by Michael Wonder on 24 Dec 2019
FDA approves first generics of Eliquis
23 December 2019 - The U.S. FDA has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce ...
Posted by Michael Wonder on 19 Dec 2019
Request for information on lamotrigine brand change
9 December 2019 - The request, dated 15 November 2019, asked for all and any advice or information or guidance that ...
Posted by Michael Wonder on 17 Dec 2019
PHARMAC brand switch: man driving through Waterview Tunnel blacked out
18 December 2019 - An Auckland man had a seizure and blacked out as he drove through Auckland's Waterview Tunnel after ...
Posted by Michael Wonder on 17 Dec 2019
Calls for answers about PHARMAC delay after epilepsy deaths
17 December 2019 - The Opposition is calling for answers from the Government about why it took two weeks for ...
Posted by Michael Wonder on 17 Dec 2019
Lamotrigine NPPA change
17 December 2019 - The request seeks all ‘communications’ between members of the PHARMAC senior leadership team, and in anticipation ...
Posted by Michael Wonder on 14 Dec 2019
FDA issues new analysis linking greater generic competition and lower generic drug prices
13 December 2019 - Greater competition among generic drug makers is associated with lower generic drug prices, according to a new ...
Posted by Michael Wonder on 10 Dec 2019
Endo launches generic version of Afinitor (everolimus) tablets in the United States
10 December 2019 - Endo International today announced that one of its operating companies, Par Pharmaceutical, has received approval for and ...
Posted by Michael Wonder on 05 Dec 2019
FDA approves first generics of Gilenya
5 December 2019 - The U.S. FDA has approved three applications for first generics of Gilenya (fingolimod) capsules for the ...
Posted by Michael Wonder on 05 Dec 2019
Epilepsy patients angry at being told symptoms all in their heads
5 December 2019 - PHARMAC funded research into whether people with epilepsy were imagining side effects from a medicine brand change ...
Posted by Michael Wonder on 05 Dec 2019
PHARMAC funded video downplays side effects of drug linked to four unexplained deaths, epilepsy patients say
5 December 2019 - Epilepsy patients are upset about a PHARMAC funded video which they say downplays the side effects of ...
Posted by Michael Wonder on 28 Nov 2019
Hikma completes its FDA response for generic Advair
27 November 2019 - Hikma Pharmaceuticals today announces that it has submitted to the US FDA its response to deficiencies in ...
Posted by Michael Wonder on 26 Nov 2019
Teva, drug makers in talks with U.S. to end generics probes
26 November 2019 - Deferred prosecution agreements among resolutions discussed. ...
Posted by Michael Wonder on 22 Nov 2019
Corbyn pledges to create state-run generics firm to cut drug prices
22 November 2019 - Labour leader Jeremy Corbyn has included in the party’s election manifesto plans to create a state-run ...